sglt2 glp-1 news Renal outcomes of inhibitors and GLP1 agonists in clinical practice GLP1 Receptor Agonists vs SGLT2-I

GLP-1 drugs are reshaping healthcare and consumer markets

Learn the signs, treatment options and how to respond in an emergency.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

This unflavored powder offers a convenient way to add collagen to your routine while maintaining a clean and minimal ingredient profile

Learn more

The same framework that predicts AD efficacy also predicts GI tolerability: the calcium signaling network operates in both brain and gut, with the same proteins producing opposite clinical consequences in different tissues